Hilton T C, Fulmer H, Abuan T, Thompson R C, Stowers S A
Department of Nuclear Medicine, St. Luke's Hospital, Jacksonville, Fla., USA.
J Nucl Cardiol. 1996 Jul-Aug;3(4):308-11. doi: 10.1016/s1071-3581(96)90090-2.
Patients in the emergency department with typical chest pain and a normal or nondiagnostic electrocardiogram have a 10% to 20% risk of nonfatal myocardial infarction. These patients can be stratified into groups of very low and very high risk for inpatient adverse cardiac events on the basis of initial 99mTc-labeled sestamibi single-photon emission computed tomographic (SPECT) perfusion imaging performed during symptoms. However, the intermediate or posthospital discharge prognosis of such patients has not been reported.
Patients (n = 150) with typical chest pain (based on a semiquantitative chest pain questionnaire) and a normal or nondiagnostic electrocardiogram underwent injection of 15 to 45 mCi 99mTc-labeled sestamibi injected during symptoms. Ninety-day follow-up history (telephone questionnaire and review of medical records) was obtained in 140 patients, and follow-up electrocardiography was performed in 72 patients. Cardiac events (death, nonfatal myocardial infarction, thrombolysis, percutaneous transluminal coronary angioplasty, or coronary artery bypass grafting) occurred before hospital discharge in 33 patients (18%), and these patients were excluded from further analysis. At follow-up, two (8%) of 25 patients with an abnormal initial scintigram and none of 87 patients with a normal scan had cardiac events (p = 0.008).
In patients with typical angina and a normal or nondiagnostic electrocardiogram, initial SPECT scintigraphy allows early accurate risk stratification. The previously observed excellent inpatient prognosis of patients with a normal scintigram appears to extend for at least 90 days of follow-up. These observations may provide a rational basis for safe and cost-effective outpatient evaluation of selected patients in the emergency department with typical angina, a normal or nondiagnostic electrocardiogram, and a normal initial 99mTc-labeled SPECT perfusion scintigram performed during symptoms.
急诊科中出现典型胸痛且心电图正常或无诊断意义的患者,发生非致命性心肌梗死的风险为10%至20%。根据症状发作时进行的初始99mTc标记的 sestamibi单光子发射计算机断层扫描(SPECT)灌注成像,这些患者可被分为住院不良心脏事件风险极低和极高的组。然而,此类患者的中期或出院后预后尚未见报道。
150例有典型胸痛(基于半定量胸痛问卷)且心电图正常或无诊断意义的患者在症状发作时注射了15至45 mCi的99mTc标记的 sestamibi。140例患者获得了90天的随访病史(电话问卷和病历审查),72例患者进行了随访心电图检查。33例患者(18%)在出院前发生了心脏事件(死亡、非致命性心肌梗死、溶栓、经皮腔内冠状动脉成形术或冠状动脉搭桥术),这些患者被排除在进一步分析之外。随访时,25例初始闪烁图异常的患者中有2例(8%)发生了心脏事件,而87例扫描正常的患者中无一例发生心脏事件(p = 0.008)。
对于有典型心绞痛且心电图正常或无诊断意义的患者,初始SPECT闪烁图可实现早期准确的风险分层。先前观察到的闪烁图正常患者良好的住院预后似乎至少可延续至90天的随访期。这些观察结果可为急诊科中具有典型心绞痛、心电图正常或无诊断意义且症状发作时初始99mTc标记的SPECT灌注闪烁图正常的特定患者进行安全且具有成本效益的门诊评估提供合理依据。